Skip to main content
AstraZeneca PLC (AZN)
NYSE: AZN · Real-Time Price · USD
186.68
-0.83 (-0.44%)
At close: Apr 28, 2026, 4:00 PM EDT
184.95
-1.73 (-0.93%)
Pre-market: Apr 29, 2026, 7:45 AM EDT

AstraZeneca Revenue

AstraZeneca had revenue of $15.29B in the quarter ending March 31, 2026, with 12.51% growth. This brings the company's revenue in the last twelve months to $60.44B, up 9.93% year-over-year. In the year 2025, AstraZeneca had annual revenue of $58.74B with 8.63% growth.

Revenue (ttm)
$60.44B
Revenue Growth
+9.93%
P/S Ratio
4.82
Revenue / Employee
$635,531
Employees
95,100
Market Cap
291.18B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202558.74B4.67B8.63%
Dec 31, 202454.07B8.26B18.03%
Dec 31, 202345.81B1.46B3.29%
Dec 31, 202244.35B6.93B18.53%
Dec 31, 202137.42B10.80B40.58%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Johnson & Johnson 96.36B
Merck & Co. 65.01B
Pfizer 62.58B
AbbVie 61.16B
Novartis AG 56.58B
Sanofi 54.60B
Novo Nordisk 48.59B
Bristol-Myers Squibb Company 48.19B
Revenue Rankings

AZN News

More News